Skip to main content

Table 1 Data collection

From: Securing jugular central venous access devices with dressings fixed to a liquid adhesive in an intensive care unit population: a randomised controlled trial

Study enrolment CVAD insertion Daily check CVAD removal 48 h post-CVAD removal
Age
Weight
Height
APACHE II Score
Skin type
• Very fair, fair, medium, olive, etc.
Skin integrity
• Good, fair, poor
Date of hospital and ICU admission
ICU admission type
• Planned, emergent, IHT
Primary reason for ICU admission
• Medical, surgical, other
Number of comorbidities
Current infections
• Blood, urinary, respiratory, etc.
Current wounds
• Yes, no
CVAD insertion site
• Left or right IJ
Placement of CVAD in IJ vein
• High, mid, low
Angle of CVAD lumens
• Down, up, horizontal
Number of CVAD lumens
Place of CVAD insertion
• ICU, OT, etc.
Antimicrobial-impregnated CVAD
• Yes, no
Inserter type
• ICU registrar, ICU consultant, anaesthetic registrar, etc.
Number of insertion attempts
Technologies used during insertion
• Ultrasound, x-ray, ECG, etc.
Hair clipped prior to CVAD insertion
• Yes, no
Dressing site
• Neck, chest, other
Diaphoretic at insertion site
• Yes, no
Facial hair at insertion site
• Yes, no
Dressing and securements in addition to ‘standard care’
• Sutures, bordered transparent dressing, tissue adhesive, etc.
Date and time of first MLA application
Staff/patient satisfaction with dressing application
• 0 = not at all satisfied, 10 = completely satisfied
Date/time of check
Reason why check not able to be completed
• Patient not available, etc.
Is randomised dressing still in situ
• Yes, no
Dressing site
• Neck, chest, other
Dressing and securements in situ
• Sutures, bordered transparent dressing, tissue adhesive, etc.
Condition of current dressing
• Clean, dry, intact, lifting at edges, etc.
How many edges of the dressing are lifting or requiring reinforcement
Complications at CVAD insertion site
• Redness, purulent discharge, pain, etc.
Has the patient mobilised, been diaphoretic, restless/agitated
• Yes, no
Signs and symptoms of skin injury/reaction
• Pain, itch, redness, rash, papules, stripping, blister, etc.
Suspected cause of MARSI or skin injury/reaction
Extent of redness, rash or maceration if applicable
Positive bloodstream infections since last daily check
• Yes, no
Number of administration sets
What is the CVAD currently being used for
• Fluids, blood products, CVP monitoring, blood sampling, etc.
Dressing changes since last daily check
• Date/time, reason for dressing change, staff/patient satisfaction, etc.
Date/time of CVC removal
Reason for CVC removal
• Treatment complete with/without complications, patient deceased, routine replacement, etc.
Complications at time of CVC removal
• Occlusion, unable to aspirate, accidental removal, suspected infection, MARSI, etc.
Signs and symptoms of skin injury/reaction
• Pain, itch, redness, etc.
Extent of redness, rash or maceration if applicable
Pain, tenderness, redness, swelling at CVC insertion site
Patient mobility at time of CVC removal
• Independent, requires assistance, bed-bound, etc.
IV antibiotics administered during CVC dwell
• Yes, no
Patient diagnosed with delirium
• Yes, no
Staff/patient satisfaction with dressing removal
• 0 = not at all satisfied, 10 = completely satisfied
Was the patient alive at 48 h after CVC removal?
• Yes, no
Date/time of death
SAEs
Results of CVC tip culture
Results of CVC insertion site swabs
Results of blood cultures
  1. APACHE Acute Physiology and Chronic Health Evaluation, CVAD central venous access device, CVP central venous pressure, ECG electrocardiogram, ICU intensive care unit, IHT inter-hospital transfer, IJ internal jugular, MARSI medical adhesive related skin injury, MLA Mastisol liquid adhesive, OT operating theatre, SAE serious adverse event